Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
LRMR Stock — Larimar Therapeutics Inc
Larimar Therapeutics Inc (LRMR)
Updated October 16, 2026.
LRMR is a Stock. Total return is -99.2% over the past 12.3 years, 477.8 points behind SPY at 378.6%.
Larimar Therapeutics is a clinical-stage biotechnology company developing treatments for rare diseases using cell penetrating peptide technology, with its lead candidate CTI-1601 currently in Phase 2 testing for Friedreich's ataxia. The company does not currently distribute dividends, as is typical for early-stage biotech firms focused on research and development rather than generating current income. This security appeals primarily to investors seeking exposure to rare disease therapeutics and willing to accept the higher risk and volatility associated with clinical-stage biotechnology companies.
LRMR dividend yield and income
Price as of 2026-10-16.
The payment date is 05/29/2020.
LRMR performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.2% over the past 12.3 years, 477.8 points behind SPY at 378.6%. Over the past year its total return — price change plus distributions reinvested — is -53.4%. Its deepest 1-year drawdown was 66.6%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -49.5% | — |
| 3M | -45.9% | — |
| 6M | -57.9% | — |
| YTD | -47.9% | — |
| 1Y | -53.4% | — |
| 2Y CAGR | — | -49.30% |
| 3Y CAGR | — | -13.60% |
| 5Y CAGR | — | -30.30% |
| 10Y CAGR | — | -26.30% |
| Since inception (12.3 years) | -99.2% | -32.20% |
LRMR key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 06/19/2014
- Distribution frequency
- None
- Last close
- $1.99 (as of 2026-10-16)
- Market cap
- $206,207,630
- Average volume
- 1691961.0
- Payment date
- 05/29/2020
- Beta
- 0.688
- Payout ratio
- 0.0%
- EPS
- $-1.99
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
LRMR risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 66.6%.
Who may consider LRMR — and who may not
It is a weaker fit for investors who need monthly cash flow (LRMR does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on LRMR
Frequently asked questions
Does LRMR pay monthly?
No. LRMR does not currently distribute.
When does LRMR pay a dividend?
LRMR does not currently distribute. The payment date is 05/29/2020.
How has LRMR performed?
Total return is -99.2% over the past 12.3 years, 477.8 points behind SPY at 378.6%. Over the past year its total return — price change plus distributions reinvested — is -53.4%. Its deepest 1-year drawdown was 66.6%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.